Doxycycline

Generic Name
Doxycycline
Brand Names
Acticlate, Adoxa, Apprilon, Atridox, Doryx, Doxy, Doxycin, Lymepak, Mondoxyne, Monodox, Morgidox, Okebo, Oracea, Periostat, Targadox, Vibramycin
Drug Type
Small Molecule
Chemical Formula
C22H24N2O8
CAS Number
564-25-0
Unique Ingredient Identifier
334895S862
Background

Doxycycline is a broad-spectrum antibiotic synthetically derived from oxytetracycline. It is a second-generation tetracycline that was first discovered in 1967. Second-generation tetracyclines exhibit lesser toxicity than first-generation tetracyclines. Doxycycline is used to treat a wide variety of gram-positive and gram-negative bacterial infections. It is also used to treat acne and malaria.

Indication

Doxycycline is indicated for the treatment of various infections by gram-positive and gram-negative bacteria, aerobes and anaerobes, as well other types of bacteria, including:

It is also used to treat infections caused by the following gram-negative microorganisms:

Associated Conditions
Acinetobacter Infections, Anthrax, Bacterial Infection caused by Enterobacter aerogenes, Bartonellosis, Brucellosis, Campylobacter Infection, Chancroid, Chlamydia Trachomatis Infection, Early Lyme Disease, Granuloma Inguinale, Infection Due to Escherichia Coli, Inhalational Anthrax, Klebsiella Infections, Lymphogranuloma Venereum, Malaria caused by Plasmodium falciparum, Nongonococcal urethritis, Plague caused by Yersinia pestis, Psittacosis, Rectal infection caused by Chlamydia Trachomatis, Relapsing fever caused by Borrelia recurrentis, Respiratory Tract Infection Bacterial, Rickettsial infectious disorders, Severe Acne, Sexually Transmitted Infections (STIs), Shigella Infection, Trachoma inclusion conjunctivitis, Tularemia, Vibrio Cholerae Infection, Acute Intestinal amebiasis, Susceptible Bacterial Infections, Uncomplicated endocervical infection, Uncomplicated urethral infection
Associated Therapies
-

Relationship of Periodontal Disease Treatment and Type 2 Diabetes Mellitus in the Gullah Population

First Posted Date
2013-02-25
Last Posted Date
2018-10-04
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
113
Registration Number
NCT01798225

Effect of a Commonly Used Antibiotic, Doxycycline, in Women With Polycystic Ovarian Syndrome

First Posted Date
2013-02-11
Last Posted Date
2016-01-13
Lead Sponsor
University of Rochester
Target Recruit Count
10
Registration Number
NCT01788215
Locations
🇺🇸

University of Rochester, Strong Fertility Center, Rochester, New York, United States

Oral Azithromycin Versus Doxycycline in Posterior Blepharitis

Phase 2
Completed
Conditions
Interventions
First Posted Date
2013-02-05
Last Posted Date
2014-02-12
Lead Sponsor
Tehran University of Medical Sciences
Target Recruit Count
100
Registration Number
NCT01783860
Locations
🇮🇷

Rassoul Akram Hospital, Tehran, Iran, Islamic Republic of

Antibiotics and Hydroxychloroquine in Crohn's

First Posted Date
2013-02-04
Last Posted Date
2019-10-31
Lead Sponsor
Royal Liverpool University Hospital
Target Recruit Count
59
Registration Number
NCT01783106
Locations
🇬🇧

Royal Liverpool and Broadgreen Unversity Hospitals Trust, Liverpool, Merseyside, United Kingdom

Non-Invasive Treatment of Abdominal Aortic Aneurysm Clinical Trial

Phase 2
Completed
Conditions
Interventions
First Posted Date
2012-12-28
Last Posted Date
2021-11-26
Lead Sponsor
University of Maryland, Baltimore
Target Recruit Count
261
Registration Number
NCT01756833
Locations
🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

🇺🇸

Omaha VAMC, Omaha, Nebraska, United States

🇺🇸

University of South Florida Health Center, Tampa, Florida, United States

and more 19 locations

Doxycycline for COPD in HIV-Infected Patients

First Posted Date
2012-12-06
Last Posted Date
2022-07-21
Lead Sponsor
Weill Medical College of Cornell University
Target Recruit Count
61
Registration Number
NCT01744093
Locations
🇺🇸

Genetic Medicine, New York, New York, United States

Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy

First Posted Date
2012-11-16
Last Posted Date
2013-12-10
Lead Sponsor
Sun Yat-sen University
Target Recruit Count
14
Registration Number
NCT01727973
Locations
🇨🇳

Zhongshan Ophthalmic Center, Guangzhou, Guangdong, China

Comparison of Two Preemptive Treatment Strategies of Panitumumab Mediated Skin Toxicity and Assessment of QoL in Patient With Ras-wt Colorectal Cancer

First Posted Date
2012-08-20
Last Posted Date
2016-04-19
Lead Sponsor
AIO-Studien-gGmbH
Target Recruit Count
88
Registration Number
NCT01668498
Locations
🇩🇪

Universitätsklinikum Mannheim, III. Medizinische Klinik, Mannheim, Germany

Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment Commenced

First Posted Date
2012-08-10
Last Posted Date
2014-12-15
Lead Sponsor
Ostergotland County Council, Sweden
Target Recruit Count
160
Registration Number
NCT01661985
Locations
🇸🇪

R&D dept of Local Health Care, Östergötland county council, Linköping, Sweden

Management of Etonogestrel Subdermal Implant-related Bleeding

Phase 3
Completed
Conditions
Interventions
First Posted Date
2012-08-07
Last Posted Date
2021-01-26
Lead Sponsor
Petra M. Casey
Target Recruit Count
82
Registration Number
NCT01658995
Locations
🇺🇸

Mayo Clinic in Rochester, Rochester, Minnesota, United States

© Copyright 2024. All Rights Reserved by MedPath